TY - JOUR T1 - Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand JF - Sexually Transmitted Infections JO - Sex Transm Infect SP - 103 LP - 103 DO - 10.1136/sextrans-2013-051037 VL - 90 IS - 2 AU - Nick Wilson AU - Jane Morgan AU - Michael G Baker Y1 - 2014/03/01 UR - http://sti.bmj.com/content/90/2/103.abstract N2 - To prevent cervical cancer, a government-funded vaccination programme against human papillomavirus (HPV) infection started in New Zealand in 2008. After an initial catch-up phase, vaccination with a quadrivalent vaccine was routinely offered from year 2011 onwards to girls in school year 8 (typically age 12 years) or in primary care settings at age 12.To better understand the impact of this vaccination programme, we examined national prescription data from the government's pharmaceutical purchasing agency (PHARMAC). From this agency, we obtained national data for both imiquimod cream (ie, Aldara) and for podophyllum resin-based products … ER -